- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
Orally active, selective retinoic acid receptor gamma (RARγ) agonist that reduces heterotopic ossification (HO) in cultures and in animal models in vivo.
Palovarotene is an orally active, selective retinoic acid receptor gamma (RARγ) agonist that reduces heterotopic ossification (HO) in cultures (15-300 nM) and in murine and rat fibrodysplasia ossificans progressiva (FOP) models in vivo (1 mg/kg rat, 0.27-2.49 mg/kg mouse or 15-100 μg/mouse via daily p.o.).
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | 2-8°C |
| SMILES string | CC1(C2=CC(CN3C=CC=N3)=C(/C=C/C4=CC=C(C=C4)C(O)=O)C=C2C(C)(CC1)C)C |
| InChI | 1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+ |
| InChI key | YTFHCXIPDIHOIA-DHZHZOJOSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 2528.88
-
询价
-
询价
-
询价
-
询价
-
¥ 1653.62
-
询价
-
¥ 787.34
-
询价
-
¥ 26022.64
-
¥ 26846.31
-
¥ 65710.50
-
询价
-
¥ 42661.77
-
¥ 21702.96
-
询价
-
询价
-
询价
-
询价
微信小程序
7X24小时在线咨询